Artificial intelligence in cardiovascular prevention: new ways will open new doors

M Ciccarelli, F Giallauria, A Carrizzo… - Journal of …, 2023 - journals.lww.com
Prevention and effective treatment of cardiovascular disease are progressive issues that
grow in tandem with the average age of the world population. Over recent decades, the …

Application of artificial intelligence in acute coronary syndrome: a brief literature review

H Wang, Q Zu, J Chen, Z Yang, MA Ahmed - Advances in Therapy, 2021 - Springer
Artificial intelligence (AI) is defined as a set of algorithms and intelligence to try to imitate
human intelligence. Machine learning is one of them, and deep learning is one of those …

Design of decision tree structure with improved BPNN nodes for high-accuracy locomotion mode recognition using a single IMU

Y Han, C Liu, L Yan, L Ren - Sensors, 2021 - mdpi.com
Smart wearable robotic system, such as exoskeleton assist device and powered lower limb
prostheses can rapidly and accurately realize man–machine interaction through locomotion …

[HTML][HTML] Machine Learning for Early Prediction of Major Adverse Cardiovascular Events After First Percutaneous Coronary Intervention in Patients With Acute …

P Zhang, L Wu, TT Zou, ZX Zou, JX Tu… - JMIR Formative …, 2024 - formative.jmir.org
Background: The incidence of major adverse cardiovascular events (MACEs) remains high
in patients with acute myocardial infarction (AMI) who undergo percutaneous coronary …

Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina

C Li, M Liu, W Chen, T Jiang, L Ling - European Journal of Clinical …, 2022 - Springer
Purpose This study aims to compare the effects of ticagrelor and clopidogrel on platelet
function, cardiovascular prognosis, and bleeding in patients with unstable angina pectoris …

Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management

S Nie, S Zhang, Y Zhao, X Li, H Xu, Y Wang… - Advances in …, 2024 - Springer
Acute coronary syndrome (ACS) is a leading cause of death worldwide. Prompt and
accurate diagnosis of acute myocardial infarction (AMI) or ACS is crucial for improved …

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial

M Mehdizadeh Parizi, R Golchin Vafa… - Journal of …, 2023 - Wiley Online Library
Background. Dual antiplatelet therapy with a P2Y12 inhibitor (eg, clopidogrel and ticagrelor)
and aspirin is recommended for at least one year after percutaneous coronary intervention …

Modelos de identificación de enfermedades cardiovasculares implementando técnicas de aprendizaje máquina: una revisión sistemática de la literatura

J Mardini-Bovea, D Salcedo… - Revista Ibérica de …, 2024 - search.proquest.com
El uso de técnicas de Aprendizaje Automático (AA) en el área de la salud, específicamente
en la identificación de enfermedades cardiovasculares (IEC), ha tenido un impacto …

替格瑞洛联合复方血栓通胶囊治疗不稳定型心绞痛的临床观察

柴松波, 杜亚康, 张淑娟, 兀江波, 张伟萍… - 中国 …, 2023 - journal.china-pharmacy.com
目的观察替格瑞洛联合复方血栓通胶囊治疗不稳定型心绞痛的疗效及安全性. 方法将2021 年1
月-2022 年12 月三门峡市中医院收治的120 例不稳定型心绞痛气阴两虚兼血瘀型患者随机分为 …

[HTML][HTML] Factors predicting the occurrence of net adverse clinical and cerebral events in patients with acute coronary syndrome treated with clopidogrel or ticagrelor in …

M Huang, D Li, L Li, Y Wang, L Zhang… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background This study aimed to establish the factors influencing the clinical benefits of
ticagrelor and clopidogrel for acute coronary syndrome (ACS) patients undergoing …